Recruiting
Phase 2

Dabrafenib + Trametinib + PDR001 In Colorectal Cancer

Sponsor:

Massachusetts General Hospital

Code:

NCT03668431

Conditions

Metastatic Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dabrafenib

Trametinib

PDR001

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information